Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Firy Inc. (FIRY) vs Zoetis Inc (ZTS) Price & Performance

Zoetis IncTrade

Price performance (Past 24H)

Key statistics

Firy Inc. vs Zoetis Inc — how do they compare? Firy Inc. trades at $10.21 (market cap $159.51M), while Zoetis Inc trades at $74.9 (market cap $31.14B). The key difference: Zoetis Inc is far larger — about 195.2× Firy Inc.'s market cap, and Zoetis Inc pays a 2.81% dividend while Firy Inc. pays none. Which is the better fit depends on your goals.

FIRYZTS
Market Cap
$159.51M$31.14B
Sector
Consumer CyclicalHealth
52-Week High
$12.45$156.76
52-Week Low
$2.28$71.91
Enterprise Value
$103.18M$38.70B
Dividend Yield
2.81%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Firy Inc.

FIRY trades at $10.48, up 0.29% today, with a bullish technical outlook from moving averages. The company shows improving revenue trends ($104.5M in 2025) but continues to report significant losses (-$70.41M net income). Recent developments include a $719 million legal victory and corporate rebranding from Skillz Inc. Analyst sentiment remains mixed with a 60% hold rating.

The stock presents speculative potential from legal wins and revenue stabilization, but persistent negative margins and cash burn (-$86.41M net cash flow) pose substantial risks. Upside depends on achieving profitability, while downside risk remains elevated from ongoing operational losses.

Zoetis Inc

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

About Firy Inc.

Firy Inc. operates a mobile gaming platform in the United States, Israel, China, Malta, Hong Kong, Cyprus, and other international markets. The company operates through two segments: Skillz and RZR. Its Skillz platform enables game developers to monetize their content by integrating real-money tournaments, virtual prizes, and social competition features directly into multiplayer games.

Read more on FIRY

About Zoetis Inc

Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns slightly less than half of total revenue from production animals (cattle, pigs, poultry, and so on), and more than half from companion animal (dogs, horses, cats) products make up the other half. Its U.S. business is heavily skewed toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.

Read more on ZTS